Search Medical Condition
Please enter condition
Please choose location from dropdown

Common Cold Clinical Trials

A listing of Common Cold medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (40) clinical trials

Currently it is challenging to distinguish viral infections that cannot be treated with antibiotics from bacterial infections which do respond to antibiotics. Clinical Research Associates in Nashville, TN is conducting a research study to test a diagnostic device. This device is designed to identify your body's immune response to a ...

Phase N/A

Are you experiencing symptoms of a cold, such as a runny nose, cough, or sore throat within the last 40 hours? Act Fast! ACRC Trials is conducting a clinical trial for the common cold. The Centers for Disease Control and Prevention (CDC) reports: Common colds are the main reason that ...

Phase

The purpose of this study is to test an investigational nasal rinse medication to treat smell loss that arose after a cold, flu, or sinus infection.  This study will last about 6 weeks, there will be 2 – 3 study visits. Each visit will last about 30 minutes. Compensation will ...

Phase N/A

Our office is helping with a medical research study that is evaluating an investigational cough medication for children. Learn more about this opportunity. In this research study, doctors want to evaluate an investigational drug that contains an approved ingredient found in many cough medications. Participation in this study will last ...

Phase

Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units

Background, Literature Survey and Justification of The Study 1.1. Introduction -lactams efficacy depends primarily from the time interval during which the plasma concentration remains above the minimal inhibitory concentration (MIC) of the antibiotic against the target organism(s) (Craig, 1998). It is generally accepted that the free concentration of the antibiotic ...

Phase N/A

Exploratory Study of Intrapulmonary Microdosing of Gram-negative Optical Imaging Detection Probe

The primary objective of this study is to deliver a BAC TWO microdose to 3 ventilated controls and 9 patients to assess the imaging parameters of BAC TWO over human autofluorescence and to assess if gram-negative bacteria can be detected in vivo in situ within the distal lung. The primary ...

Phase N/A

Targeted AntiBiotics for Chronic Obstructive Pulmonary Disease

P. aeruginosa represents a potentially significant cause of acute exacerbation of COPD (AECOPD) and is possibly associated with significant morbidity and mortality. Despite this, the role of P. aeruginosa in the course of COPD is less well characterized, and evidence based guidelines for management and treatment of the bacteria are ...

Phase

Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine Isoniazid in HIV+ Patients

Single-arm, single-center, Phase I/II clinical trial, in two Groups. Individuals with HIV infection taking EFV and two nucleoside reverse transcriptase inhibitors (NRTI) who have undetectable HIV viral load and an indication for treatment of LTBI, will be switched to DTG with tenofovir/emtricitabine for at least two months and will receive ...

Phase

Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis

Community-acquired pneumonia (CAP) is a heterogeneous disease causing great morbidity, mortality and health care burden globally. Typing methods for discriminating different clinical conditions of the same disease are essential to a better management of CAP. Traditional typing systems based separately on clinical manifestations (such as PSI and CURB-65), pathogens(bacterial types, ...

Phase N/A

Efficacy Safety and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Adults

This randomized, observer-blind, placebo-controlled multicenter, Phase 3 study will be conducted at multiple sites. The composition of the Quadrivalent VLP Influenza Vaccine to be used in this study includes a mix of recombinant H1, H3, and two B hemagglutinin proteins expressed as VLPs for the 2017-2018 influenza virus strains. Approximately ...

Phase